Lakartidningen
2013-01-01
[It is possible to reduce drug-drug interactions. Interactions were corrected frequently by patient-specific letters to general practitioners].
Olof Cronberg, Cecilia Nordquist, Stephan Quittenbaum
Index: Lakartidningen. 110(48) , 2176-7, (2013)
Full Text: HTML
Abstract
Related Articles:
Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.
2015-10-01
[Drug Metab. Dispos. 43 , 1408-16, (2015)]
HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics.
2015-01-01
[Arch. Pharm. Res. 38 , 691-704, (2015)]
Evaluation of the effect of TM208 on the activity of five cytochrome P450 enzymes using on-line solid-phase extraction HPLC-DAD: a cocktail approach.
2013-04-01
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 923-924 , 29-36, (2013)]
Effects of Polygonum multiflorum on the activity of cytochrome P450 isoforms in rats.
2015-01-01
[Pharmazie 70(1) , 47-54, (2015)]
Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail.
1999-09-24
[Anal. Bioanal. Chem 406(18) , 4453-64, (2014)]